Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Iván Archilla"'
Autor:
Carolina González Abós, Claudia Lorenzo, Iván Archilla, Nuria Vidal-Robau, Miriam Cuatrecasas, Fabio Ausania
Publikováno v:
BMC Surgery, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The adoption of robotic pancreaticoduodenectomy (PD) has increased in recent years for the treatment of pancreatic head tumors and periampullary lesions. Some potential benefits seem to be demonstrated; however, obtaining specimen
Externí odkaz:
https://doaj.org/article/d519f2bb486548e3b5fc71e3d73c81f0
Autor:
Leire Pedrosa, Carles Foguet, Helena Oliveres, Iván Archilla, Marta García de Herreros, Adela Rodríguez, Antonio Postigo, Daniel Benítez-Ribas, Jordi Camps, Miriam Cuatrecasas, Antoni Castells, Aleix Prat, Timothy M. Thomson, Joan Maurel, Marta Cascante
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Existing immune signatures and tumor mutational burden have only modest predictive capacity for the efficacy of immune check point inhibitors. In this study, we developed an immune-metabolic signature suitable for personalized ICI therapies. A classi
Externí odkaz:
https://doaj.org/article/cc714daff1e1497f851797bec7a612cf
Autor:
Petrushevska, Gordana, Bogdanovska, Magdalena, Zdravkoski, Panche, Antovic, Svetozar, Dzambaz, Darko, Karagjozov, Panche, de Cuba, Erienne M.V., Beverdam, Frédérique, Jansen, Jan, Vermaas, Maarten, Gašljević, Gorana, Kjær-Frifeldt, Sanne, Lindebjerg, Jan, Strous, Maud, Vogelaar, Jeroen F., Bulkmans, Nicole W.J., van Baarlen, Joop, Mekenkamp, Leonie, Hoekstra, Ronald, Sie, Mark, Cuatrecasas, Miriam, Simonetti, Sara, Rodrigo, María Teresa, Sanz, Iván Archilla, Guerrero Pineda, Jose, Leeuwis-Fedorovich, Natalja E., Talsma, Koen A., Souza da Silva, Ricella M., Lacle, Miangela M., Koopman, Miriam, Dekker, Jan Willem T., van Tilburg, Arjan, Nuciforo, Paolo, Villalobos Alberú, Xenia, Landolfi, Stefania, Zucchiatti, Adriana, Witteveen, Emma, Bordbar, Arad, Hendriks, Mathijs P., Arensman, René, Natu, Shonali, Maka, Noori, Mesker, Wilma E., Tollenaar, Rob A.E.M., Polack, Meaghan, Smit, Marloes A., van Pelt, Gabi W., Putter, Hein, Meershoek-Kleinenbarg, Elma, Roodvoets, Annet G.H., Crobach, Augustinus S.L.P., Gelderblom, Hans, Fontes e Sousa, Mário, Borralho Nunes, Paula, Cruz, João, Raimundo, Ana, Silva, Nelson, Brito, Maria J., Terpstra, Valeska, Zakhartseva, L.M., Al Dieri, Raed, Fléjou, Jean-François, Feakins, Roger, Dequeker, Els, Vink, Geraldine R., van Krieken, J.Han J.M., Polack, M., Smit, M.A., van Pelt, G.W., Roodvoets, A.G.H., Meershoek-Klein Kranenbarg, E., Putter, H., Gelderblom, H., Crobach, A.S.L.P., Terpstra, V., Petrushevska, G., Gašljević, G., Kjær-Frifeldt, S., de Cuba, E.M.V., Bulkmans, N.W.J., Vink, G.R., Al Dieri, R., Tollenaar, R.A.E.M., van Krieken, J.H.J.M., Mesker, W.E.
Publikováno v:
In ESMO Open April 2024 9(4)
Publikováno v:
Annals of diagnostic pathology. 38
Autor:
Jordi Sarto, Berta Caballol, Joan Berenguer, Iban Aldecoa, Álvaro Carbayo, Daniel Santana, Ivan Archilla, Carles Gaig, Francesc Graus, Julián Panés, Albert Saiz
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 15 (2022)
Ustekinumab, a monoclonal antibody against interleukin (IL)-12 and IL-23 approved for the treatment of Crohn’s disease, has shown to be an effective therapy with a favourable safety profile. Clinical trials and real-world studies have reported very
Externí odkaz:
https://doaj.org/article/a10147c4113145eb9dbe8d4be37e0a00
Autor:
Núria Vidal Robau, Gabriela Caballero, Ivan Archilla, Andrea Ladino, Sara Fernández, Valentín Ortiz-Maldonado, Montserrat Rovira, Marta Gómez-Hernando, Julio Delgado, María Suárez-Lledó, Carlos Fernández de Larrea, Olga Balagué, Gerard Frigola, Abel Muñoz, Estrella Ortiz, Teresa Ribalta, Miguel J. Martinez, Maria Angeles-Marcos, Marta Español-Rego, Azucena González, Daniel Benitez-Ribas, Eugenia Martinez-Hernandez, Pedro Castro, Iban Aldecoa
Publikováno v:
Free Neuropathology, Vol 3 (2022)
Introduction: Chimeric antigen receptor (CAR) T-cell therapy is a promising immunotherapy for the treatment of refractory hematopoietic malignancies. Adverse events are common, and neurotoxicity is one of the most important. However, the physiopathol
Externí odkaz:
https://doaj.org/article/00d9ba14db9a4b1fbb3ea1b2032c2a8c